# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Falcon Scott (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX002-SYN
- Date: 2026-01-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Harrow-Mbeki, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week follow-up of an elevated blood pressure with home readings, seen the same day in wilderness and expedition medicine. **S**

## History of present illness

Mr. Scott returns two weeks after his pre-expedition assessment, on the day of his consultation with Dr. Nwankwo-Lund. He took two home readings morning and evening for seven days with a validated upper-arm monitor; the average of the 28 readings is 138/88 mmHg, with no single reading above 150/95. He has no headache, chest pain, breathlessness, or visual change. He stopped his pipe on his quit date a week ago and takes varenicline, with mild nausea after the morning dose. He has started to use less salt. He asked whether a diagnosis of high blood pressure would count against him in leading the sledge journeys; he was told it is common, treatable, and not in itself a reason to stop him. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Seven-day average 138/88 mmHg (28 readings) |
| Symptoms | None |
| Tobacco | No pipe for a week; varenicline with mild nausea |
| Concern | Whether the diagnosis limits his role on the expedition |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No headache or visual change |
| Gastrointestinal | Positive | Mild nausea after the morning varenicline dose |
| Psychiatric | Negative | Sleeping well; no low mood; occasional vivid dreams |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) **S**

## Allergies

- No known allergy **S**

## Objective

BP 140/88 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 72.2 kg; BMI 24.1 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 140/88, pulse 66, weight 72.2 kg |
| Cardiovascular | Regular rhythm; normal heart sounds; no murmur; no radio-femoral delay; no abdominal bruit |
| Respiratory | Clear to auscultation bilaterally |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential hypertension, stage 1** (I10). The elevated office reading at intake is now confirmed by home readings: a seven-day average of 138/88 mmHg is stage 1 hypertension. Intake tests show no target-organ damage or secondary cause: sinus rhythm without left ventricular hypertrophy on the ECG, creatinine 0.92 mg/dL (eGFR 107), potassium 4.2 mmol/L, sodium 140 mmol/L, fasting glucose 92 mg/dL, HbA1c 5.3%, TSH 2.1 mIU/L, and LDL cholesterol 122 mg/dL. No urine sample was given at intake. His ten-year cardiovascular risk is low: about 5% by the Pooled Cohort Equations counting him as a smoker, and below the 7.5% threshold by the PREVENT equations, so the guideline advises lifestyle measures for three to six months before medicine. Dr. Nwankwo-Lund agrees, and advises an angiotensin receptor blocker, rather than a thiazide or a beta-blocker, if medicine is needed, started at least four weeks before departure. **S**
   - Lifestyle: sodium below 2,300 mg a day, aiming lower, more fruit and vegetables, endurance training at least 150 minutes a week, alcohol within limits, and no tobacco.
   - Home readings for a week before each visit.
   - Urine albumin-to-creatinine ratio before the next visit.
   - Review in four weeks; decide about medicine at about three months.
2. **Nicotine dependence, pipe tobacco** (F17.290). No tobacco for a week since his quit date; nausea on varenicline is mild. **S**
   - Take varenicline after food with a full glass of water.
   - Counseling call each week.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique, average of two readings (target below 130/80 mmHg) | Every visit | Completed today | 140/88 mmHg |
| Self-management | Home blood pressure monitoring to confirm the diagnosis and guide treatment | At diagnosis and when treatment changes | Completed today | Seven-day average 138/88 mmHg; confirms stage 1 hypertension |
| Examination | Weight, BMI, and cardiac auscultation | Every visit | Completed today | 72.2 kg, BMI 24.1; normal heart sounds |
| Laboratory | Basic metabolic panel: sodium, potassium, creatinine, eGFR | Baseline; 2 to 4 weeks after starting an ARB; then every 6 months on an ARB | Up to date | Baseline at intake: sodium 140, potassium 4.2 mmol/L, creatinine 0.92 mg/dL, eGFR 107; not on an ARB |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Deferred | Not done: no urine sample was given at intake, and the gap was noticed today. Ordered, to be collected before the next visit |
| Laboratory | Lipid panel and HbA1c or fasting glucose | At diagnosis, then yearly | Up to date | At intake: LDL cholesterol 122 mg/dL, HbA1c 5.3%, fasting glucose 92 mg/dL |
| Laboratory | TSH | At diagnosis, then as indicated | Up to date | 2.1 mIU/L at intake |
| Imaging | Twelve-lead ECG | At diagnosis, then as indicated | Up to date | At intake: sinus rhythm; no left ventricular hypertrophy |
| Imaging | Echocardiogram | Only for stage 2 hypertension, suspected left ventricular hypertrophy, or clinical change | Not indicated | Stage 1 hypertension with no sign of left ventricular hypertrophy |
| Examination | Fundoscopic examination | Yearly | Due | At the preventive visit |
| Survey | Ten-year cardiovascular risk estimate | At diagnosis, then yearly | Completed today | About 5% by the Pooled Cohort Equations as a smoker; below 7.5% by PREVENT; lifestyle first |
| Survey | PHQ-9 depression screen | Yearly with hypertension, and before and after a long isolated posting | Up to date | PHQ-9 3 at intake |
| Survey | GAD-7 anxiety screen | Before and after a long isolated posting | Up to date | GAD-7 4 at intake |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent since the quit date a week ago; mild nausea on varenicline |
| Referral | Wilderness and expedition medicine consultation | Once, before a long polar expedition | Completed today | Seen by Dr. Nwankwo-Lund today |
| Self-management | Expedition nutrition plan: energy, weight, and vitamin C | Planned before departure, then weekly in the field | Ordered | Plan made with the consultant today |
| Self-management | Frostbite and hypothermia prevention and field treatment training | Before departure | Ordered | Wilderness first aid course with cold-injury modules booked |

## Goal progress

- Home blood pressure average below 130/80 mmHg before departure. In progress; target 2026-05-26. **S**
- No tobacco from the quit date, confirmed at each visit. In progress; target 2026-05-26. **S**
- Complete a wilderness first aid course with frostbite, hypothermia and evacuation practice before departure. In progress; target 2026-04-21. **S**
- A written expedition medical plan covering nutrition and vitamin C, cold injury, altitude, mental health support, medicines and evacuation, agreed before departure. In progress; target 2026-05-26. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Circulation 2025;152(11):e114-e218) (2025), American Heart Association and American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, hypertension monograph (2026), Aether Forge
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024), Wilderness Medical Society
- Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019), Wilderness Medical Society
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force

## Follow-up

- Review in four weeks with home readings and the urine test. **S**
- Next scheduled visit 2026-02-24: six-week review: blood pressure on lifestyle measures, tobacco, urine albumin, dental and hearing results. **S**
